Risk factors for nosocomial bloodstream infection caused by multidrug resistant gram-negative bacilli in pediatrics

Brazilian Journal of Infectious Diseases

Volumn 11, Issue 2, 2007, Pages 267-271

  Arnoni, Mariana Volpe ^a,b   Berezin, Eitan N ^a   Martino, Marinês D V ^a  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Bloodstream infection; Gram negative bacilli; Risk factors

Indexed keywords

CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BRAZIL; CASE CONTROL STUDY; CENTRAL VENOUS CATHETER; CITROBACTER; CONTROL STRATEGY; CONTROLLED STUDY; ENTEROBACTER; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; KLEBSIELLA; LETHALITY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PEDIATRICS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 34547100759     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702007000200020     Document Type: Article

References (28)

1. Raymond J. Epidemiology of nosocomial infections in pediatrics. Pathol Biol (Paris) 2000;48(10):879-84.
2. Gray J.W. A 7-year study of bloodstream infections in an English children's hospital. Eur J Pediatr 2004;163(9):530-5.
3. Ford-Jones E.L., Mindorff C.M., Langley J.M., et al. Epidemiologic study of 4684 hospital-acquired infections in pediatric patients. Pediatr Infect Dis J 1989;8(10):668-75.
4. Biedenbach D.J., Moet G.J., Jones R.N. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 2004;50(1):59-69.
5. Pollock E., Ford-Jones E.L., Corey M., et al. Use of the pediatric risk of mortality score to predict nosocomial infection in a pediatric intensive care unit. Crit Care Med 1991;19(2):160-5.
6. Singh-Naz N., Sprague B.M., Patel K.M., Pollack M.M. Risk factors for nosocomial infection in critically ill children: a prospective cohort study. Crit Care Med 1996;24(5)875-8.
7. Lyytikainen O., Lumio J., Sarkkinen H., et al. Nosocomial bloodstream infections in finnish hospitals during 1999-2000. Clin Infect Dis 2002;35(2):e14-9.
8. Wisplinghoff H., Seifert, H., Tallent S.M., et al. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J 2003;22(8):686-91.
9. Gayvallet-Montredon N., Sauvestre C., Bergeret M., et al. Nosocomial bacteremias in pediatrics. Arch Pediatr 2002;9(7):679-84.
10. Tseng Y.C., Chiu Y.C., Wang J.H., et al. Nosocomial bloodstream infection in a neonatal intensive care unit of a medical center: a three-year review. J Microbiol Immunol Infect 2002;35(3):168-72.
11. Pong A., Bradley J.S. Clinical challenges of nosocomial infections caused by antibiotic-resistant pathogens in pediatrics. Semin Pediatr Infect Dis 2004;15(1):21-9.
12. Cordero L., Rau R., Taylor D., Ayers L.W. Enteric Gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit. Am J Infect Control 2004;32(4):189-95.
13. Zinner S.H. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on Gram-positive and resistant bacteria. Clin Infect Dis 1999;29(3):490-4.
14. Chang,M.R., Carvalho N.C., Oliveira A.L., et al. Surveillance of pediatric infections in a teaching hospital in Mato Grosso do Sul, Brazil. Braz J Infect Dis 2003;7(2):149-60.
15. Raymond J., Bergeret M., Gendrel D. Impact of bacterial resistance on severe infections. Arch Pediatr 2001;8 Suppl 4: 697s-704s.
16. Gray J., Gossain S., Morris K. Three-year survey of bacteremia and fungemia in a pediatric intensive care unit. Pediatr Infect Dis J 2001;20(4):416-21.
17. Schiappa D.A., Hayden M.K., Matushek M.G., et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996;174(3):529-36.
18. Kim Y.K., Pai H., Lee H.J., et al. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002;46(5):1481-91.
19. Sader H.S., Gales A.C., Pfaller M.A., et al. Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis 2001;5(4):200-14.
20. Horan T.C., Gaynes R.P. Surveillance of nosocomial infections. In: Mayhall C.G. ed. Hospital Epidemiology and Infection Control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2004. pp.1659-702.
21. Medeiros A.A. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. Clin Infect Dis 1997;24 Suppl 1:S19-45.
22. Pornull K.J., Goransson E., Rytting A.S., Dornbusch K. Extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. in European septicaemia isolates. J Antimicrob Chemother 1993; 32(4):559-70.
23. Rahal J.J., Urban C., Horn D., et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998;280(14):1233-7.
24. Harris A.D., Smith D., Johnson J.A., et al. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 2002;34(3):340-5.
25. El Amari E.B., Chamot E., Auckenthaler R., et al. Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis 2001; 33(11):1859-64.
26. Liu C.P., Wang N.Y., Lee C.M., et al. Nosocomial and community-acquired Enterobacter cloacae bloodstream infection: risk factors for and prevalence of SHV-12 in multi-resistant isolates in a medical centre. J Hosp Infect 2004;58(1):63-77.
27. Paterson D.L., Ko W.C., Von Gottberg A., et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis 2003;39:31-7.
28. Kang C.I., Kim S.H., Park W.B., et al. Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005;49(2):760-6.